Antoniou KM - Search Results

1

Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF).

Antoniou KM, Margaritopoulos GA, Soufla G, Symvoulakis E, Vassalou E, Lymbouridou R, Samara KD, Kappou D, Spandidos DA, Siafakas NM. Antoniou KM, et al. J Recept Signal Transduct Res. 2010 Aug;30(4):262-9. doi: 10.3109/10799893.2010.489227. J Recept Signal Transduct Res. 2010. PMID: 20536315

2

Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).

Antoniou KM, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Perisinakis K, Tzortzaki EG, Siafakas NM, Bouros DE. Antoniou KM, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2004 Jun;21(2):105-10. Sarcoidosis Vasc Diffuse Lung Dis. 2004. PMID: 15281431 Clinical Trial.

3

Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis.

Antoniou KM, Alexandrakis M, Tzanakis N, Tsiligianni I, Tzortzaki EG, Siafakas NM, Bouros DE. Antoniou KM, et al. Respiration. 2005 Jan-Feb;72(1):32-8. doi: 10.1159/000083398. Respiration. 2005. PMID: 15753632

4

Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.

Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Tzanakis N, et al. Eur J Intern Med. 2005 Apr;16(2):105-112. doi: 10.1016/j.ejim.2004.09.013. Eur J Intern Med. 2005. PMID: 15833676

5

Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis.

Tsiligianni I, Antoniou KM, Kyriakou D, Tzanakis N, Chrysofakis G, Siafakas NM, Bouros D. Tsiligianni I, et al. Among authors: antoniou km. BMC Pulm Med. 2005 Jun 24;5:8. doi: 10.1186/1471-2466-5-8. BMC Pulm Med. 2005. PMID: 15978129 Free PMC article.

6

Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.

Schiza SE, Antoniou KM, Economidou FN, Siafakas NM. Schiza SE, et al. Among authors: antoniou km. Pulm Pharmacol Ther. 2005;18(6):381-9. doi: 10.1016/j.pupt.2004.12.001. Pulm Pharmacol Ther. 2005. PMID: 15998594 Review.

7

Cytokine network in the pathogenesis of idiopathic pulmonary fibrosis.

Antoniou KM, Alexandrakis MG, Siafakas NM, Bouros D. Antoniou KM, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Jun;22(2):91-104. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 16053024 Review.

8

Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b.

Antoniou KM, Tzortzaki EG, Alexandrakis MG, Zervou M, Tzanakis N, Sfiridaki K, Bouros DE, Siafakas NM. Antoniou KM, et al. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Oct;22(3):204-9. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 16315783

9

Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.

Antoniou KM, Malagari K, Tzanakis N, Perisinakis K, Symvoulakis EK, Karkavitsas N, Siafakas NM, Bouros D. Antoniou KM, et al. BMC Pulm Med. 2006 Feb 16;6:4. doi: 10.1186/1471-2466-6-4. BMC Pulm Med. 2006. PMID: 16483363 Free PMC article. Clinical Trial.

10

Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.

Antoniou KM, Pataka A, Bouros D, Siafakas NM. Antoniou KM, et al. Pulm Pharmacol Ther. 2007;20(5):453-61. doi: 10.1016/j.pupt.2006.01.002. Epub 2006 Mar 3. Pulm Pharmacol Ther. 2007. PMID: 16516512 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters